These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 8725721)
1. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease. Miller GJ; Bauer KA; Barzegar S; Cooper JA; Rosenberg RD Thromb Haemost; 1996 May; 75(5):767-71. PubMed ID: 8725721 [TBL] [Abstract][Full Text] [Related]
2. Thrombin generation markers and coronary heart disease risk factors in a Polish population sample. Musiał J; Pajak A; Undas A; Kawalec E; Topór-Madry R; Pazucha T; Grzywacz M; Szczeklik A Thromb Haemost; 1997 Apr; 77(4):697-700. PubMed ID: 9134645 [TBL] [Abstract][Full Text] [Related]
3. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Erem C Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444 [TBL] [Abstract][Full Text] [Related]
4. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166 [TBL] [Abstract][Full Text] [Related]
5. Activation of the coagulant pathway in cigarette smokers. Miller GJ; Bauer KA; Cooper JA; Rosenberg RD Thromb Haemost; 1998 Mar; 79(3):549-53. PubMed ID: 9531038 [TBL] [Abstract][Full Text] [Related]
6. Factor VII and fibrinogen levels examined by age, sex, and other atherosclerotic risk factors in a Japanese population. The Jichi Medical School Cohort Study. Ishikawa S; Kario K; Nago N; Kayaba K; Hiraoka J; Matsuo H; Goto T; Miyamoto T; Tsutsumi A; Nakamura Y; Shimada K; Inoue K; Igarashi M Thromb Haemost; 1997 May; 77(5):890-3. PubMed ID: 9184398 [TBL] [Abstract][Full Text] [Related]
7. High intakes of trans monounsaturated fatty acids taken for 2 weeks do not influence procoagulant and fibrinolytic risk markers for CHD in young healthy men. Sanders TA; Oakley FR; Crook D; Cooper JA; Miller GJ Br J Nutr; 2003 Jun; 89(6):767-76. PubMed ID: 12828793 [TBL] [Abstract][Full Text] [Related]
8. Does inflammatory proteolytic activity contribute to the increased factor IX activation peptide in men at high risk of coronary heart disease? A preliminary study. Miller GJ; Bauer KA; Howarth DJ; Mitchell JP; Cooper JA Thromb Haemost; 2002 Mar; 87(3):415-20. PubMed ID: 11916072 [TBL] [Abstract][Full Text] [Related]
9. Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study. Yarnell J; Yu S; McCrum E; Arveiler D; Hass B; Dallongeville J; Montaye M; Amouyel P; Ferrières J; Ruidavets JB; Evans A; Bingham A; Ducimetière P; Int J Epidemiol; 2005 Apr; 34(2):268-75. PubMed ID: 15319403 [TBL] [Abstract][Full Text] [Related]
10. Gemfibrozil reduces plasma prothrombin fragment F1 + 2 concentration, a marker of coagulability, in patients with coronary heart disease. Wilkes HC; Meade TW; Barzegar S; Foley AJ; Hughes LO; Bauer KA; Rosenberg RD; Miller GJ Thromb Haemost; 1992 May; 67(5):503-6. PubMed ID: 1519208 [TBL] [Abstract][Full Text] [Related]
11. [Role of hemostatic markers in the pathogenesis of coronary diseases]. Russo C Recenti Prog Med; 2002 Feb; 93(2):75-7. PubMed ID: 11887348 [TBL] [Abstract][Full Text] [Related]
12. Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina. Lowe GD; Wood DA; Douglas JT; Riemersma RA; Macintyre CC; Takase T; Tuddenham EG; Forbes CD; Elton RA; Oliver MF Thromb Haemost; 1991 Apr; 65(4):339-43. PubMed ID: 2057913 [TBL] [Abstract][Full Text] [Related]
13. Coagulation factor VII in middle-aged women with and without coronary heart disease. Eriksson-Berg M; Silveira A; Orth-Gomér K; Hamsten A; Schenck-Gustafsson K Thromb Haemost; 2001 May; 85(5):787-92. PubMed ID: 11372669 [TBL] [Abstract][Full Text] [Related]
14. Cross-sectional study of complement C3 as a coronary risk factor among men and women. Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease. Lowe GD; Rumley A; McMahon AD; Ford I; O'Reilly DS; Packard CJ; Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1529-34. PubMed ID: 15205218 [TBL] [Abstract][Full Text] [Related]
16. Association of overall adiposity rather than body mass index with lipids and procoagulant factors. De Lorenzo F; Mukherjee M; Kadziola Z; Suleiman S; Kakkar VV Thromb Haemost; 1998 Oct; 80(4):603-6. PubMed ID: 9798978 [TBL] [Abstract][Full Text] [Related]
17. Factor VII activity state in coronary artery disease. Hoffman C; Shah A; Sodums M; Hultin MB J Lab Clin Med; 1988 Apr; 111(4):475-81. PubMed ID: 3351380 [TBL] [Abstract][Full Text] [Related]
18. Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study. Yarnell J; McCrum E; Rumley A; Patterson C; Salomaa V; Lowe G; Evans A Eur Heart J; 2005 Feb; 26(4):332-42; discussion 317-8. PubMed ID: 15618045 [TBL] [Abstract][Full Text] [Related]
19. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels. Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067 [TBL] [Abstract][Full Text] [Related]
20. Plasma fibrinogen--a major coronary risk factor. Stone MC; Thorp JM J R Coll Gen Pract; 1985 Dec; 35(281):565-9. PubMed ID: 4093900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]